2,772
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Assessing the impact of pain-linked Nav1.7 variants: An example of two variants with no biophysical effect

, , , , , , , , , , , , & show all
Pages 208-228 | Received 09 Nov 2020, Accepted 23 Dec 2020, Published online: 25 Jan 2021

References

  • Yu FH, Catterall WA. Overview of the voltage-gated sodium channel family. Genome Biol. 2003;4(3):1–7.
  • Cox JJ, Olmsted SS, Keeler E, et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature. 2006;444(December):3–7.
  • Cummins TR, Dib-Hajj SD, Waxman SG. Electrophysiological properties of mutant Nav1.7 sodium channels in a painful inherited neuropathy. J Neurosci. 2004;24(38):8232–8236.
  • Fertleman CR, Baker MD, Parker KA, et al. SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron. 2006;52(5):767–774.
  • Faber CG, Hoeijmakers JG, Ahn HS, et al. Gain of function NaV1.7 mutations in idiopathic small fiber neuropathy. Annals of Neurology. 2012;71(1):26–39.
  • Chinn S, Caldwell W, Gritsenko K. Fibromyalgia pathogenesis and treatment options update. Curr Pain Headache Rep. 2016;20(4):1–10.
  • Farmer C, Cox JJ, Fletcher EV, et al. Splice variants of Nav1.7 sodium channels have distinct β subunit-dependent biophysical properties. PLoS ONE. 2012;7(7):e41750.
  • Lopez-Santiago LF, Brackenbury WJ, Chen C, et al. Na+ channel Scn1b gene regulates dorsal root ganglion nociceptor excitability in vivo. J Biol Chem. 2011;286(26):22913–22923.
  • Haehner A, Hummel T, Heinritz W, et al. Mutation in Nav1.7 causes high olfactory sensitivity. Eur J Pain. 2018;22:1767–1773.
  • Zhang Z, Schmelz M, Segerdahl M, et al. Exonic mutations in SCN9A (NaV1.7) are found in a minority of patients with erythromelalgia. Scand J Pain. 2014;5(4):217–225.
  • Brouwer BA, Merkies ISJ, Gerrits MM, et al. Painful neuropathies: the emerging role of sodium channelopathies. J Peripher Nerv Syst. 2014;19(2):53–65.
  • Kapetis D, Sassone J, Yang Y, et al. Network topology of NaV1.7 mutations in sodium channel-related painful disorders. BMC Syst Biol. 2017;11(1):1–16.
  • Tang Z, Chen Z, Tang B, et al. Primary erythromelalgia: A review. Orphanet J Rare Dis. 2015;10(1):1–11.
  • Shen H, Liu D, Wu K, et al. Structures of human Nav1.7 channel in complex with auxiliary subunits and animal toxins. Science. 2019;363(6433):1303–1308.
  • Waterhouse AM, Procter JB, Martin DM, et al. Jalview Version 2-A multiple sequence alignment editor and analysis workbench. Bioinformatics. 2009;25(9):1189–1191.
  • Webb B, Sali A. Comparative protein structure modeling using MODELLER. Curr Protoc Bioinforma. 2016;54. ii, 5.6.1–5.6.37, 2016. DOI:https://doi.org/10.1002/cpbi.3.
  • Grasso D, Subramaniam K, Butkus M, et al. A review of non-DLVO interactions in environmental colloidal systems. Rev Environ Sci Biotechnol. 2002;1(1):17–38.
  • Beard JM, Shockett PE, O’Reilly JP. Substituted cysteine scanning in D1-S6 of the sodium channel hNav1.4 alters kinetics and structural interactions of slow inactivation. Biochim Biophys Acta - Biomembr. 2020;1862(2):183129.
  • Chahine M, O’Leary ME. Regulatory role of voltage-gated Na+ channel β subunits in sensory neurons. Front. Pharmacol. 2011;2(70):1–8.
  • Vandewauw I, De Clercq K, Mulier M, et al. A TRP channel trio mediates acute noxious heat sensing. Nature. 2018;555(7698):662–666.
  • Lampert A, O’Reilly AO, Reeh P, et al. Sodium channelopathies and pain. Pflugers Arch Eur J Physiol. 2010;460(2):249–263.
  • Cheng X, Dib-Hajj SD, Tyrrell L, et al. Deletion mutation of sodium channel NaV1.7 in inherited erythromelalgia: enhanced slow inactivation modulates dorsal root ganglion neuron hyperexcitability. Brain. 2011;134(7):1972–1986.
  • Dib-Hajj SD, Rush AM, Cummins TR, et al. Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons. Brain. 2005;128(8):1847–1854.
  • Choi JS, Dib-Hajj SD, Waxman SG. Inherited erythermalgia: limb pain from an S4 charge-neutral Na channelopathy. Neurology. 2006;67(9):1563–1567.
  • Hampl M, Eberhardt E, O’Reilly AO, et al. Sodium channel slow inactivation interferes with open channel block. Sci Rep. 2016;6:1–11.
  • Lampert A, Stühmer W, Waxman SG. Sodium Channels. eLS. 2015;1–7.
  • Vargas-Alarcon G, Alvarez-Leon E, Fragoso JM, et al. A SCN9A gene-encoded dorsal root ganglia sodium channel polymorphism associated with severe fibromyalgia. BMC Musculoskelet Disord. 2012;13(1):p. 23.
  • Yen LT, Hsu YC, Lin JG, et al. Role of ASIC3, Nav1.7 and Nav1.8 in electroacupuncture-induced analgesia in a mouse model of fibromyalgia pain. Acupunct Med. 2018;36(2):110–116.
  • Lampert A, Dib-Hajj SD, Tyrrell L, et al. Size matters: erythromelalgia mutation S241T in Nav1.7 alters channel gating. J Biol Chem. 2006;281(47):36029–36035.
  • Lampert A, O’Reilly AO, Dib-Hajj SD, et al. A pore-blocking hydrophobic motif at the cytoplasmic aperture of the closed-state Nav1.7 channel is disrupted by the erythromelalgia- associated F1449V mutation. J Biol Chem. 2008;283(35):24118–24127.
  • Theile JW, Jarecki BW, Piekarz AD, et al. Nav1.7 mutations associated with paroxysmal extreme pain disorder, but not erythromelalgia, enhance Navβ4 peptide-mediated resurgent sodium currents. J Physiol. 2011;589(3):597–608.
  • Ciotu CI, Tsantoulas C, Meents J, et al. Noncanonical ion channel behaviour in pain. Int J Mol Sci. 2019;20(18):1–18.
  • Goldin AL. Mechanisms of sodium channel inactivation. Curr Opin Neurobiol. 2003;13(3):284–290.
  • Vilin Y, Ruben P. Slow inactivation in voltage-gated sodium channels: molecular substrates and contributions to channelopathies. Cell Biochem Biophys. 2001;35:171–190.
  • Brackenbury WJ, Isom LL. Na+ channel β subunits: overachievers of the ion channel family. Front Pharmacol. 2011 Sept;2:1–11. SEP.
  • Molinarolo S, Granata D, Carnevale V, et al. Mining protein evolution for insights into mechanisms of voltage-dependent sodium channel auxiliary subunits. Handb Exp Pharmacol. 2018;246:33–49.
  • Laedermann CJ, Syam N, Pertin M, et al. β1- and β3- voltage-gated sodium channel subunits modulate cell surface expression and glycosylation of Nav1.7 in HEK293 cells. Front Cell Neurosci. 2013;7(AUG):1–12.
  • Catterall WA. Voltage-gated sodium channels at 60: structure, function and pathophysiology. J Physiol. 2012;590(11):2577–2589.
  • Hull JM, Isom LL. Voltage-gated sodium channel β subunits: the power outside the pore in brain development and disease. Neuropharmacology. 2018;132:43–57.
  • Dib-Hajj SD, Yang Y, Black JA, et al. The Nav1.7 sodium channel: from molecule to man. Nat Rev Neurosci. 2013;14(1):49–62.
  • Raymond CK, Castle J, Garrett-Engele P, et al. Expression of alternatively spliced sodium channel α-subunit genes. Unique splicing patterns are observed in dorsal root ganglia. J Biol Chem. 2004;279(44):46234–46241.
  • Rühlmann AH, Körner J, Hausmann R, et al. Uncoupling sodium channel dimers restores the phenotype of a pain-linked Na v 1.7 channel mutation. Br J Pharmacol. 2020;177(19):4481–4496.
  • Chatelier A, Dahllund L, Eriksson A, et al. Biophysical properties of human Nav1.7 splice variants and their regulation by protein kinase A. J Neurophysiol. 2008;99(5):2241–2250.
  • Yang Y, Huang J, Mis MA, et al. Nav1.7-A1632G mutation from a family with inherited erythromelalgia: enhanced firing of dorsal root ganglia neurons evoked by thermal stimuli. J Neurosci. 2016;36(28):7511–7522.
  • Adams PJ, Garcia E, David LS, et al. CaV2.1 P/Q-type calcium channel alternative splicing affects the functional impact of familial hemiplegic migraine mutations: implications for calcium channelopathies. Channels. 2009;3(2):110–121.
  • Jo HG, Wudarczyk O, Leclerc M, et al. Effect of odor pleasantness on heat-induced pain: an fMRI study. Brain Imaging Behav. 2020. DOI:https://doi.org/10.1007/s11682-020-00328-0.
  • Weiss J, Pyrski M, Jacobi E, et al. Loss-of-function mutations in sodium channel Nav 1.7 cause anosmia. Nature. 2011;472(7342):186–190.
  • Komine Y, Takao K, Miyakawa T, et al. Behavioral Abnormalities Observed in Zfhx2-Deficient Mice. PLoS One. 2012;7(no):12.
  • Habib AM, Matsuyama A, Okorokov AL, et al. A novel human pain insensitivity disorder caused by a point mutation in ZFHX2. Brain. 2018;141(2):365–376.
  • McDonnell A, Schulman B, Ali Z, et al. Inherited erythromelalgia due to mutations in SCN9A: natural history, clinical phenotype and somatosensory profile. Brain. 2016;139(4):1052–1065.
  • Heyne HO, Baez-Nieto D, Iqbal S, et al. Predicting functional effects of missense variants in voltage-gated sodium and calcium channels. Sci Transl Med. 2020;12(556):8–11.
  • Reimann F, Cox JJ, Belfer I, et al. Pain perception is altered by a nucleotide polymorphism in SCN9A. Proc Natl Acad Sci U S A. 2010;107(11):5148–5153.
  • Eijkenboom I, Sopacua M, Hoeijmakers JGJ, et al. Yield of peripheral sodium channels gene screening in pure small fibre neuropathy. J Neurol Neurosurg Psychiatry. 2019;90(3):342–352.
  • Meents J, Lampert A. Studying sodium channel gating in heterologous expression systems. In Advanced Patch-Clamp Analysis for Neuroscientists (Neuromethods), ed. Korngreen A. 2016;113(3):37–65.
  • Waxman SG, Merkies IS, Gerrits MM, et al. Sodium channel genes in pain-related disorders: phenotype-genotype associations and recommendations for clinical use. Lancet Neurol. 2014;13(11):1152–1160.
  • Clatot J, Hoshi M, Wan X, et al. Voltage-gated sodium channels assemble and gate as dimers. Nat Commun. 2017;8(1):1–14.
  • Shiers S, Klein RM, Price TJ. Quantitative differences in neuronal subpopulations between mouse and human dorsal root ganglia demonstrated with RNAscope in situ hybridization. Pain. 2020;161(10):2410–2424.
  • Rostock C, Schrenk-Siemens K, Pohle J, et al. Human vs. Mouse Nociceptors – similarities and Differences. Neuroscience. 2018;387(December):13–27.
  • Meents JE, Fischer MJM, McNaughton PA. Agonist-induced sensitisation of the irritant receptor ion channel TRPA1. J Physiol. 2016;594(22):6643–6660.
  • Meents JE, Ciotu CI, Fischer MJM. Trpa1: a molecular view. J Neurophysiol. 2019;121(2):427–443.
  • Han C, Hoeijmakers JGJ, Ahn H-S, et al. Impaired slow-inactivation and DRG neuron hyperexcitability. Neurology. 2012;78:1635–1643.
  • Han C, Hoeijmakers JGJ, Liu S, et al. Functional profiles of SCN9A variants in dorsal root ganglion neurons and superior cervical ganglion neurons correlate with autonomic symptoms in small fibre neuropathy. Brain. 2012;135(9):2613–2628.
  • Kist AM, Sagafos D, Rush AM, et al. SCN10A mutation in a patient with erythromelalgia enhances C-fiber activity dependent slowing. PLoS One. 2016;11(9):1–19.
  • Eberhardt M, Nakajima J, Klinger AB, et al. Inherited pain sodium channel Nav1.7 A1632T mutation causes erythromelalgia due to a shift of fast inactivation. J Biol Chem. 2014;289(4):1971–1980.
  • Meents J, Bressan E, Sontag S, et al. The role of Nav1.7 in human nociceptors : insights from human induced pluripotent stem cell – derived sensory neurons of erythromelalgia patients. Pain. 2019;160(6):1327–1341.
  • Chambers SM, Fasano CA, Papapetrou EP, et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol. 2009;27(3):275–280.
  • Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663–676.
  • Eberhardt E, Havlicek S, Schmidt D, et al. Pattern of functional TTX-resistant sodium channels reveals a developmental stage of human iPSC- and ESC-derived nociceptors. Stem Cell Reports. 2015;5(3):305–313.
  • Kerth CM, Hautvast P, Körner J, et al. Phosphorylation of a chronic pain mutation in the voltage-gated sodium channel Nav1.7 increases voltage sensitivity. J Biol Chem. 2020;296:100227. accepted.
  • Han C, Dib-Hajj SD, Lin Z, et al. Early- and late-onset inherited erythromelalgia: genotype-phenotype correlation. Brain. 2009;132(7):1711–1722.